+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Vials Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 144 Pages
  • June 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6113774
The Vials Market is expected to grow from USD 12.058 billion in 2025 to USD 15.915 billion in 2030, at a CAGR of 5.71%.

Biotechnology Advancements and Investments

Biotechnology remains a cornerstone of the vials market, with its applications spanning pharmaceuticals, agriculture, and molecular gastronomy. Significant investments are fueling research and development (R&D) in this sector, increasing the demand for vials as essential laboratory components. For instance, in 2024, ARCH Venture Partners allocated substantial funding to support biotech innovation, backing companies like Vir Biotechnology, Alnylam Pharmaceuticals, VBI Vaccines, Brii Biosciences, and Sana Biotechnology, which focus on advanced therapeutics, including COVID-19 treatments. Quanterix is advancing clinical testing technologies, while Twist Biosciences develops gene-editing tools for therapeutic and vaccine development. Bellerophon’s inhaled nitric oxide delivery systems, approved for emergency use by the FDA in 2023, address respiratory distress in COVID-19 patients. Conagen’s synthetic biology R&D, aimed at sustainable green chemicals, further exemplifies the push for eco-friendly solutions. These investments, driven by the need to address global health and environmental challenges, are expected to heighten the demand for vials, which are critical for storing and handling sensitive biological materials during R&D and production processes.

Supportive Government Policies

Favorable government policies are catalyzing market growth by promoting impact investments and R&D in biotechnology and related fields. For example, in 2025, the European Union targeted 3.5% of GDP for R&D spending to foster innovation, as outlined by the Federal Funding Advisory Service for Research and Innovation. In India, the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) are formulating the "National Guidelines for Stem Cell Therapy," with 47 collaborative projects recommended for funding in 2024. These initiatives enhance biotechnological research, increasing the need for vials in laboratories for sample storage, testing, and development. Such government-backed efforts ensure sustained demand for vials as an indispensable component of scientific research, driving market expansion over the forecast period.

Growth in Personal Care and Nutraceuticals

The rising demand for personal care products and nutraceuticals, particularly among health-conscious urban consumers, is another key driver. Increasing disposable incomes have shifted consumer preferences toward premium and luxury products, including phytochemical-based nutraceuticals and clean-label skincare free of harmful chemicals. This trend has prompted market players to expand their product portfolios to include innovative, health-focused offerings, necessitating vials for both product development and retail packaging. For instance, vials are used to store active ingredients during R&D and as premium packaging for high-end personal care products, such as serums and essential oils. The growing urban population’s focus on wellness and sustainability further amplifies this demand, propelling the vials market.

Regional Insights

North America holds a significant market share, driven by substantial biotech investments, advanced healthcare infrastructure, and high consumer spending on personal care and nutraceuticals. The United States, in particular, benefits from robust R&D ecosystems and regulatory support for biotechnological advancements. The Asia-Pacific region is the fastest-growing market, fueled by increasing urbanization, rising disposable incomes, and government initiatives in countries like India and China to bolster biotech and healthcare sectors. Europe also contributes significantly, with strong policy frameworks supporting R&D and sustainable product development.

Market Challenges

The vials market faces challenges related to supply chain constraints and raw material costs, particularly for high-quality glass and plastic vials required in biotechnology and pharmaceuticals. Additionally, ensuring compatibility with diverse applications, from sterile pharmaceutical storage to consumer-facing personal care products, requires ongoing innovation in vial design and materials. Regulatory compliance for vials used in medical and food applications also adds complexity, potentially increasing production costs.

Conclusion

The vials market is set for robust growth through 2028, driven by biotechnology advancements, supportive government policies, and rising demand for personal care and nutraceutical products. Investments in R&D, particularly in North America and Asia-Pacific, are increasing the need for vials in laboratories and product development. The shift toward premium, health-focused consumer goods further boosts demand for vials in packaging applications. However, challenges like supply chain constraints and regulatory compliance require strategic solutions to sustain market momentum. Industry players must focus on innovation and scalability to capitalize on these growth opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others).

Segmentation

By Capacity

  • Up to 2 ml
  • 3 ml - 5 ml
  • 5 ml - 7 ml
  • 8 ml and above

By Material

  • Glass
  • Borosilicate glass
  • Fused Silica
  • Polymer
  • Plastic
  • Thermoplastics
  • HDPE
  • Poly Vinyl Chloride
  • Polycarbonate
  • Polypropylene
  • Thermosets
  • Melamine Formaldehyde
  • Phenol Formaldehyde
  • PolyUrea Formaldehyde
  • Others

By Filling Technology

  • Net weight fillers
  • Rotary fillers
  • Volumetric fillers
  • Other fillers

By End User

  • Personal Care
  • Chemicals
  • Healthcare
  • Hospitals
  • Pharmaceuticals
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

Table of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. VIALS MARKET BY CAPACITY
5.1. Introduction
5.2. Up to 2 ml
5.3. 3 ml - 5 ml
5.4. 5 ml - 7 ml
5.5. 8 ml and above
6. VIALS MARKET BY MATERIAL
6.1. Introduction
6.2. Glass
6.2.1. Borosilicate glass
6.2.2. Fused Silica
6.3. Polymer
6.4. Plastic
6.5.1. Thermoplastics
6.5.1.1. HDPE
6.5.1.2. Poly Vinyl Chloride
6.5.1.3. Polycarbonate
6.5.1.4. Polypropylene
6.5.2. Thermosets
6.5.2.1. Melamine Formaldehyde
6.5.2.2. Phenol Formaldehyde
6.5.2.3. PolyUrea Formaldehyde
6.5.2.4. Others
7. VIALS MARKET BY FILLING TECHNOLOGY
7.1. Introduction
7.2. Net weight fillers
7.3. Rotary fillers
7.4. Volumetric fillers
7.5. Other fillers
8. VIALS MARKET BY END-USER
8.1. Introduction
8.2. Personal Care
8.3. Chemicals
8.4. Healthcare
8.5. Hospitals
8.6. Pharmaceuticals
8.7. Research Laboratories
9. VIALS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Italy
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. Taiwan
9.6.5. Thailand
9.6.6. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Amcor plc
11.2. Gerresheimer AG
11.3. SCHOTT AG
11.4. West Pharmaceutical Services, Inc.
11.5. Becton, Dickinson and Company
11.6. AptarGroup, Inc.
11.7 Corning Incorporated
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations

Companies Mentioned

  • Amcor plc
  • Gerresheimer AG
  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company
  • AptarGroup, Inc.
  • Corning Incorporated

Table Information